I have seen some chat on this board regarding the potential content of today's presentation i.e. will they be covering this and that, they need to be updating on x and y, what's the plan post-covid etc.
This is all good, but my view is the only way to ensure you get all the answers you want is to put questions forward in advance. I have tabled at least five questions around concerns I have - institutional investors, share price depression, objectives, home-testing kit competition, why should private investors put money in etc.
I am sure this is only scratching the surface; but if any of you want to make your views known, you should engage with the board rather than just leaving comments here.
Q1 2022 is the next key update i.e. spin offs and FY results I believe at end-March.
Until then, I expect to see a number of high-value contracts for respiratory diseases throughout this period which will maintain the SP between 18p and 24p imo.
For those that are patient, I think we will be rewarded. But as bamb mentions below, turn off. It is not worth checking the SP on this one too often, just wait for RNS's and review then which is what I will be doing.
You should have cashed out or top-sliced at least, at those levels. Still not too late if you do this now, as still 3 x if you bought in at 6p. What's stopping you? Should always top-slice, say 30%, to manage the risk. DYOR
You clearly don't care, which is fine as its your opinion. But there are also many others that do care, so I guess like most things, opinion is split. I like the idea of moving the whole thing to NASDAQ; far more value and upside imo. DYOR